ＪＣＲファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/04/07 | 1,465 | 1,473 | 1,450 | 1,459 | +18 | +1.2% | 384,400 |
| 2023/04/06 | 1,390 | 1,444 | 1,385 | 1,441 | +44 | +3.1% | 547,200 |
| 2023/04/05 | 1,428 | 1,442 | 1,395 | 1,397 | -37 | -2.6% | 470,200 |
| 2023/04/04 | 1,431 | 1,454 | 1,410 | 1,434 | +3 | +0.2% | 498,000 |
| 2023/04/03 | 1,409 | 1,460 | 1,408 | 1,431 | +18 | +1.3% | 655,900 |
| 2023/03/31 | 1,496 | 1,501 | 1,407 | 1,413 | -119 | -7.8% | 1,203,200 |
| 2023/03/30 | 1,537 | 1,549 | 1,520 | 1,532 | -12 | -0.8% | 226,700 |
| 2023/03/29 | 1,534 | 1,563 | 1,525 | 1,544 | +20 | +1.3% | 368,400 |
| 2023/03/28 | 1,534 | 1,538 | 1,495 | 1,524 | -19 | -1.2% | 218,000 |
| 2023/03/27 | 1,538 | 1,546 | 1,516 | 1,543 | +13 | +0.8% | 305,000 |
| 2023/03/24 | 1,520 | 1,537 | 1,489 | 1,530 | +10 | +0.7% | 356,800 |
| 2023/03/23 | 1,478 | 1,526 | 1,465 | 1,520 | +29 | +1.9% | 424,800 |
| 2023/03/22 | 1,504 | 1,506 | 1,475 | 1,491 | +15 | +1% | 208,200 |
| 2023/03/20 | 1,503 | 1,505 | 1,475 | 1,476 | -29 | -1.9% | 277,300 |
| 2023/03/17 | 1,460 | 1,508 | 1,460 | 1,505 | +62 | +4.3% | 342,900 |
| 2023/03/16 | 1,436 | 1,451 | 1,414 | 1,443 | -19 | -1.3% | 232,300 |
| 2023/03/15 | 1,477 | 1,483 | 1,454 | 1,462 | -17 | -1.1% | 216,100 |
| 2023/03/14 | 1,484 | 1,494 | 1,453 | 1,479 | -26 | -1.7% | 300,200 |
| 2023/03/13 | 1,487 | 1,515 | 1,481 | 1,505 | -22 | -1.4% | 261,100 |
| 2023/03/10 | 1,582 | 1,589 | 1,527 | 1,527 | -79 | -4.9% | 496,600 |
| 2023/03/09 | 1,550 | 1,652 | 1,547 | 1,606 | +89 | +5.9% | 957,900 |
| 2023/03/08 | 1,492 | 1,525 | 1,486 | 1,517 | +33 | +2.2% | 428,500 |
| 2023/03/07 | 1,487 | 1,502 | 1,475 | 1,484 | +5 | +0.3% | 345,500 |
| 2023/03/06 | 1,477 | 1,488 | 1,466 | 1,479 | -6 | -0.4% | 351,000 |
| 2023/03/03 | 1,460 | 1,488 | 1,445 | 1,485 | +37 | +2.6% | 416,700 |
| 2023/03/02 | 1,413 | 1,448 | 1,405 | 1,448 | +25 | +1.8% | 422,600 |
| 2023/03/01 | 1,470 | 1,473 | 1,404 | 1,423 | -45 | -3.1% | 560,100 |
| 2023/02/28 | 1,475 | 1,483 | 1,445 | 1,468 | +19 | +1.3% | 419,400 |
| 2023/02/27 | 1,459 | 1,465 | 1,433 | 1,449 | -36 | -2.4% | 390,400 |
| 2023/02/24 | 1,509 | 1,516 | 1,455 | 1,485 | -25 | -1.7% | 420,500 |
| 2023/02/22 | 1,512 | 1,523 | 1,487 | 1,510 | -21 | -1.4% | 440,600 |
| 2023/02/21 | 1,557 | 1,559 | 1,523 | 1,531 | -26 | -1.7% | 239,300 |
| 2023/02/20 | 1,557 | 1,574 | 1,530 | 1,557 | ±0 | ±0% | 269,800 |
| 2023/02/17 | 1,581 | 1,587 | 1,553 | 1,557 | -42 | -2.6% | 277,700 |
| 2023/02/16 | 1,610 | 1,617 | 1,582 | 1,599 | +2 | +0.1% | 279,700 |
| 2023/02/15 | 1,620 | 1,620 | 1,583 | 1,597 | -15 | -0.9% | 224,400 |
| 2023/02/14 | 1,620 | 1,628 | 1,585 | 1,612 | +14 | +0.9% | 238,000 |
| 2023/02/13 | 1,615 | 1,615 | 1,583 | 1,598 | -43 | -2.6% | 305,900 |
| 2023/02/10 | 1,628 | 1,642 | 1,612 | 1,641 | -16 | -1% | 318,200 |
| 2023/02/09 | 1,646 | 1,660 | 1,617 | 1,657 | -18 | -1.1% | 416,300 |
| 2023/02/08 | 1,711 | 1,715 | 1,659 | 1,675 | -5 | -0.3% | 297,300 |
| 2023/02/07 | 1,735 | 1,735 | 1,659 | 1,680 | -61 | -3.5% | 590,800 |
| 2023/02/06 | 1,678 | 1,748 | 1,659 | 1,741 | +143 | +8.9% | 958,000 |
| 2023/02/03 | 1,653 | 1,654 | 1,587 | 1,598 | -47 | -2.9% | 307,600 |
| 2023/02/02 | 1,648 | 1,664 | 1,627 | 1,645 | +9 | +0.6% | 393,400 |
| 2023/02/01 | 1,635 | 1,680 | 1,615 | 1,636 | +41 | +2.6% | 552,100 |
| 2023/01/31 | 1,593 | 1,615 | 1,586 | 1,595 | -15 | -0.9% | 381,500 |
| 2023/01/30 | 1,624 | 1,628 | 1,597 | 1,610 | -22 | -1.3% | 309,100 |
| 2023/01/27 | 1,675 | 1,677 | 1,626 | 1,632 | -43 | -2.6% | 303,600 |
| 2023/01/26 | 1,674 | 1,691 | 1,665 | 1,675 | -12 | -0.7% | 298,500 |
401～
450
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「ＪＣＲファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
